triclabendazole 250 MG Oral Tablet

RxCUI: 2118606
RxNorm name: triclabendazole 250 MG Oral Tablet
Display name: triclabendazole 250 MG Oral Tablet
Full name: triclabendazole 250 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:59

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EGATEN	TRICLABENDAZOLE	Novartis Pharmaceuticals Corporation	5552884e-10ea-450c-9658-d3d4f33c946e	2026-06-04	Warnings, Adverse reactions	Exact identifier rxcui: 2118606

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
5552884e-10ea-450c-9658-d3d4f33c946e	triclabendazole 250 MG Oral Tablet	SCD	11	These highlights do not include all the information needed to use EGATEN safely and effectively. See full prescribing information for EGATEN. EGATEN ® (triclabendazole) tablets, for oral use Initial U.S. Approval: 2019	20250305
5552884e-10ea-450c-9658-d3d4f33c946e	triclabendazole 250 MG Oral Tablet	PSN	11	These highlights do not include all the information needed to use EGATEN safely and effectively. See full prescribing information for EGATEN. EGATEN ® (triclabendazole) tablets, for oral use Initial U.S. Approval: 2019	20250305